# ADC Therapeutics

**Canonical:** https://apis.io/providers/adc-therapeutics/  
**Website:** https://www.adctherapeutics.com/  
**APIs profiled:** 0

ADC Therapeutics SA (NYSE: ADCT) is a commercial-stage biotechnology company headquartered at the Biopôle in Lausanne, Switzerland, with US operations in New Jersey, that discovers and develops antibody drug conjugates (ADCs) for hematologic malignancies and solid tumors. Its approved product ZYNLONTA (loncastuximab tesirine-lpyl) is a CD19-directed ADC for relapsed or refractory diffuse large B-cell lymphoma, and the company is expanding it into earlier lines through the LOTIS-5 Phase 3 and LOTIS-7 Phase 1b trials alongside a preclinical and clinical ADC pipeline. It is a therapeutics developer, not a software vendor: a 2026-09-07 probe of every host it operates found no developer portal, no public API, no SDK and no machine-readable contract.

## Kin Score — 9.0 / 100 (minimal)

Scored 2026-09-07 under rubric 0.20.0.

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 17.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Security (1)

- **Adc Therapeutics Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Biotechnology, Pharmaceuticals, Oncology, Life Sciences, Healthcare, Clinical Trials, Antibody Drug Conjugates

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/adc-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.